SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001279569-18-002468
Filing Date
2018-12-13
Accepted
2018-12-13 16:28:00
Documents
102
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 20-F tv507810_20f.htm 20-F 1581263
2 EXHIBIT 4.8 tv507810_ex4-8.htm EX-4.8 414583
3 EXHIBIT 4.9 tv507810_ex4-9.htm EX-4.9 60409
4 EXHIBIT 4.10 tv507810_ex4-10.htm EX-4.10 107944
5 EXHIBIT 4.11 tv507810_ex4-11.htm EX-4.11 108653
6 EXHIBIT 4.12 tv507810_ex4-12.htm EX-4.12 578152
7 EXHIBIT 12.1 tv507810_ex12-1.htm EX-12.1 11574
8 EXHIBIT 12.2 tv507810_ex12-2.htm EX-12.2 11636
9 EXHIBIT 13.1 tv507810_ex13-1.htm EX-13.1 5971
16 GRAPHIC tv507810_img01.jpg GRAPHIC 38344
17 GRAPHIC tv507810_ex4-10img1.jpg GRAPHIC 2956
18 GRAPHIC tv507810_ex4-12img1.jpg GRAPHIC 202133
19 GRAPHIC tv507810_ex4-12img2.jpg GRAPHIC 255618
20 GRAPHIC tv507810_ex4-12img3.jpg GRAPHIC 4639
21 GRAPHIC tv507810_img02.jpg GRAPHIC 11431
22 GRAPHIC tv507810_img03.jpg GRAPHIC 12128
  Complete submission text file 0001279569-18-002468.txt   8340908

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE DOCUMENT epi-20180930.xml EX-101.INS 1035045
11 XBRL TAXONOMY EXTENSION SCHEMA epi-20180930.xsd EX-101.SCH 97642
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE epi-20180930_cal.xml EX-101.CAL 50102
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE epi-20180930_def.xml EX-101.DEF 241284
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE epi-20180930_lab.xml EX-101.LAB 601895
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE epi-20180930_pre.xml EX-101.PRE 410427
Mailing Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5
Business Address SUITE 720 999 WEST BROADWAY VANCOUVER A1 V5Z 1K5 (778) 331-0962
ESSA Pharma Inc. (Filer) CIK: 0001633932 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0930
Type: 20-F | Act: 34 | File No.: 001-37410 | Film No.: 181233531
SIC: 2834 Pharmaceutical Preparations